4//SEC Filing
Meeter Dalen 4
Accession 0000950170-24-137421
CIK 0001850906other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:34 PM ET
Size
7.2 KB
Accession
0000950170-24-137421
Insider Transaction Report
Form 4
Meeter Dalen
Chief Financial Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-12-15−209→ 1,874 total→ Common Stock (209 underlying) - Exercise/Conversion
Common Stock
2024-12-15+209→ 9,002 total
Footnotes (4)
- [F1]Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]Includes 100 shares acquired under the Issuer's employee stock purchase plan since the Reporting Person last filed a Form 4 with the Securities and Exchange Commission.
- [F3]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F4]The RSUs vest in 16 equal quarterly installments over four years measured from March 15, 2023.
Documents
Issuer
Singular Genomics Systems, Inc.
CIK 0001850906
Entity typeother
Related Parties
1- filerCIK 0001859032
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 5:34 PM ET
- Size
- 7.2 KB